No Data
FDA Is Said to See "Path Forward" for Ecstasy-based Drug
Bright Minds Rally Ends as Psychedelic Stocks Extend Volatility
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Express News | Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...
Express News | Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder
Express News | Clearmind Medicine Announces Irb Approval for FDA First-in-Human Clinical Trial of Cmnd-100 at Second Clinical Site
No Data
No Data
